Lv11
100 积分 2022-07-23 加入
Altered serum profile of the interleukin-22 system in inflammatory bowel disease
1小时前
已完结
Nonclinical Safety Profile of JADE101, a Half-Life Extended Fully Human Monoclonal Antibody Targeting APRIL for the Treatment of IgAN
27天前
已关闭
Monoclonal Antibodies
1个月前
已完结
ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aβ Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan
1个月前
已完结
IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease
1个月前
已完结
Responsiveness of Serum C‐Reactive Protein, Interleukin‐17A, and Interleukin‐17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double‐Blind, Placebo‐Controlled Trials
1个月前
已完结
PROTAC targeted protein degraders: the past is prologue
2个月前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
2个月前
已完结
OA13.02 Global Phase 2 Randomized Trial of BNT327 (Pumitamig; PD-L1 x VEGF-A bsAb) + Chemotherapy for 1L ES-SCLC: Dose Optimization Analysis
2个月前
已关闭
OA13.02 Global Phase 2 Randomized Trial of BNT327 (Pumitamig; PD-L1 x VEGF-A bsAb) + Chemotherapy for 1L ES-SCLC: Dose Optimization Analysis
2个月前
已关闭
皖公网安备34019202002308
